130 related articles for article (PubMed ID: 11095952)
1. Anandamide and 2-arachidonoylglycerol inhibit fatty acid amide hydrolase by activating the lipoxygenase pathway of the arachidonate cascade.
Maccarrone M; Salvati S; Bari M; Finazzi-Agró
Biochem Biophys Res Commun; 2000 Nov; 278(3):576-83. PubMed ID: 11095952
[TBL] [Abstract][Full Text] [Related]
2. Full inhibition of spinal FAAH leads to TRPV1-mediated analgesic effects in neuropathic rats and possible lipoxygenase-mediated remodeling of anandamide metabolism.
Starowicz K; Makuch W; Korostynski M; Malek N; Slezak M; Zychowska M; Petrosino S; De Petrocellis L; Cristino L; Przewlocka B; Di Marzo V
PLoS One; 2013; 8(4):e60040. PubMed ID: 23573230
[TBL] [Abstract][Full Text] [Related]
3. Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol.
Ho WS; Randall MD
Br J Pharmacol; 2007 Mar; 150(5):641-51. PubMed ID: 17245358
[TBL] [Abstract][Full Text] [Related]
4. Anandamide induces apoptosis in human cells via vanilloid receptors. Evidence for a protective role of cannabinoid receptors.
Maccarrone M; Lorenzon T; Bari M; Melino G; Finazzi-Agro A
J Biol Chem; 2000 Oct; 275(41):31938-45. PubMed ID: 10913156
[TBL] [Abstract][Full Text] [Related]
5. Fatty acid amide hydrolase: biochemistry, pharmacology, and therapeutic possibilities for an enzyme hydrolyzing anandamide, 2-arachidonoylglycerol, palmitoylethanolamide, and oleamide.
Fowler CJ; Jonsson KO; Tiger G
Biochem Pharmacol; 2001 Sep; 62(5):517-26. PubMed ID: 11585048
[TBL] [Abstract][Full Text] [Related]
6. Enhanced anandamide degradation is associated with neuronal apoptosis induced by the HIV-1 coat glycoprotein gp120 in the rat neocortex.
Maccarrone M; Piccirilli S; Battista N; Del Duca C; Nappi G; Corasaniti MT; Finazzi-Agrò A; Bagetta G
J Neurochem; 2004 Jun; 89(5):1293-300. PubMed ID: 15147522
[TBL] [Abstract][Full Text] [Related]
7. Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase.
Bisogno T; Melck D; De Petrocellis L; Bobrov MYu ; Gretskaya NM; Bezuglov VV; Sitachitta N; Gerwick WH; Di Marzo V
Biochem Biophys Res Commun; 1998 Jul; 248(3):515-22. PubMed ID: 9703957
[TBL] [Abstract][Full Text] [Related]
8. Anandamide hydrolysis by human cells in culture and brain.
Maccarrone M; van der Stelt M; Rossi A; Veldink GA; Vliegenthart JF; Agrò AF
J Biol Chem; 1998 Nov; 273(48):32332-9. PubMed ID: 9822713
[TBL] [Abstract][Full Text] [Related]
9. Human mast cells take up and hydrolyze anandamide under the control of 5-lipoxygenase and do not express cannabinoid receptors.
Maccarrone M; Fiorucci L; Erba F; Bari M; Finazzi-Agrò A; Ascoli F
FEBS Lett; 2000 Feb; 468(2-3):176-80. PubMed ID: 10692582
[TBL] [Abstract][Full Text] [Related]
10. Effect of nitric oxide donors on membrane tritium accumulation of endocannabinoids and related endogenous lipids.
Thors L; Fowler CJ
Eur J Pharmacol; 2009 Oct; 621(1-3):10-8. PubMed ID: 19715690
[TBL] [Abstract][Full Text] [Related]
11. FAAH and anandamide: is 2-AG really the odd one out?
Di Marzo V; Maccarrone M
Trends Pharmacol Sci; 2008 May; 29(5):229-33. PubMed ID: 18394720
[TBL] [Abstract][Full Text] [Related]
12. Fatty acid amide hydrolase but not monoacyl glycerol lipase controls cell death induced by the endocannabinoid 2-arachidonoyl glycerol in hepatic cell populations.
Siegmund SV; Wojtalla A; Schlosser M; Zimmer A; Singer MV
Biochem Biophys Res Commun; 2013 Jul; 437(1):48-54. PubMed ID: 23806692
[TBL] [Abstract][Full Text] [Related]
13. Anandamide activates human platelets through a pathway independent of the arachidonate cascade.
Maccarrone M; Bari M; Menichelli A; Del Principe D; Agrò AF
FEBS Lett; 1999 Mar; 447(2-3):277-82. PubMed ID: 10214961
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of FAAH confers increased stem cell migration via PPARα.
Wollank Y; Ramer R; Ivanov I; Salamon A; Peters K; Hinz B
J Lipid Res; 2015 Oct; 56(10):1947-60. PubMed ID: 26263913
[TBL] [Abstract][Full Text] [Related]
15. Selective inhibition of anandamide cellular uptake versus enzymatic hydrolysis--a difficult issue to handle.
Fowler CJ; Tiger G; Ligresti A; López-Rodríguez ML; Di Marzo V
Eur J Pharmacol; 2004 May; 492(1):1-11. PubMed ID: 15145699
[TBL] [Abstract][Full Text] [Related]
16. Further evidence for the existence of a specific process for the membrane transport of anandamide.
Ligresti A; Morera E; Van Der Stelt M; Monory K; Lutz B; Ortar G; Di Marzo V
Biochem J; 2004 May; 380(Pt 1):265-72. PubMed ID: 14969584
[TBL] [Abstract][Full Text] [Related]
17. Characterization of palmitoylethanolamide transport in mouse Neuro-2a neuroblastoma and rat RBL-2H3 basophilic leukaemia cells: comparison with anandamide.
Jacobsson SO; Fowler CJ
Br J Pharmacol; 2001 Apr; 132(8):1743-54. PubMed ID: 11309246
[TBL] [Abstract][Full Text] [Related]
18. Fatty acid amide hydrolase inhibitors--progress and potential.
Khanna IK; Alexander CW
CNS Neurol Disord Drug Targets; 2011 Aug; 10(5):545-58. PubMed ID: 21631410
[TBL] [Abstract][Full Text] [Related]
19. Methylation and acetylation of 15-hydroxyanandamide modulate its interaction with the endocannabinoid system.
Amadio D; Fezza F; Catanzaro G; Incani O; van Zadelhoff G; Finazzi Agrò A; Maccarrone M
Biochimie; 2010 Apr; 92(4):378-87. PubMed ID: 20096328
[TBL] [Abstract][Full Text] [Related]
20. Further insights into the regulation of human FAAH by progesterone and leptin implications for endogenous levels of anandamide and apoptosis of immune and neuronal cells.
Gasperi V; Fezza F; Spagnuolo P; Pasquariello N; Maccarrone M
Neurotoxicology; 2005 Oct; 26(5):811-7. PubMed ID: 16154199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
